Adaptive Deep Brain Stimulation (aDBS) Study (Early Adapter) Part II

计划入组 25 人 · 首次发布于 2025 年 8 月 6 日

ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)

计划入组 500,000 人 · 首次发布于 2024 年 3 月 7 日

Adapting Diet and Action for Everyone (ADAPT+)

计划入组 95 人 · 首次发布于 2021 年 3 月 16 日

ADAIR

adapter inhibitor (autoimmune disease)

Multiple sclerosis(Adaptive)

Aptevo Therapeutics

United States

Adaptive Phage Therapeutics, Inc.

United States

ANM Adaptive Neuromodulation GmbH

Germany

Aptevo Therapeutics Secures $2.1 Million in Financing to Advance Immune-Oncology Pipeline

Aptevo Advances APVO711: Novel Bispecific Antibody Combining PD-L1 Checkpoint Inhibition with CD40 Immune Activation

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Advance Multispecific Cancer Immunotherapy Pipeline